fgf-1
Recombinant proteinexperimental
Clinical trial activity
8 trials · 9 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Sep 1, 2005 (NCT00425178)
Timeline
Indications
Studied for
- Constriction, Pathologic · Phase 1
- Coronary Artery Disease · Phase 2
- Coronary Disease · Phase 2
- Diabetes Mellitus · Phase 1
- Diabetic Foot · Phase 1
- Intermittent Claudication · Phase 1
- Mesenchymal Stem Cell Transplantation · Phase 1
- Myocardial Ischemia · Phase 2
- Parkinson Disease · Phase 1
- Peripheral Arterial Disease · Phase 1
- Spinal Cord Injuries · Phase 3
- Varicose Ulcer · Phase 1
- Wounds and Injuries · Phase 1
Mechanism of action
- Acidic fibroblast growth factorSupplementation
FGF1 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- fgf-1
- fgf-1 141
- fibroblast growth factor-1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06516939 | N/A | Jun 10, 2024 | Shanghai Dermatology Hospital |
| NCT05493462 | Phase 1 | Sep 30, 2022 | Zhittya Genesis Medicine, Inc. |
| NCT04235868 | Phase 1 | Jan 20, 2020 | People's Liberation Army of China |
| NCT03229031 | Phase 3 | Mar 7, 2018 | Eusol |
| NCT00424866 | Phase 1 | Dec 1, 2014 | Department of Veteran Affairs, Venturis Therapeutics |
| NCT00916292 | Phase 1 | Nov 1, 2012 | Phage Pharmaceuticals, Inc. |
| NCT00117936 | Phase 2 | Sep 1, 2008 | Mercy Gilbert Medical Center, Venturis Therapeutics |
| NCT00425178 | Phase 1 | Sep 1, 2005 | Venturis Therapeutics, Warren General Hospital |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (9)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Venturis Therapeutics | For profit | 3 | 3 | 2 | 2005 |
| Department of Veteran Affairs | Government | 1 | 0 | 1 | 2014 |
| Eusol | For profit | 1 | 1 | 1 | 2018 |
| Mercy Gilbert Medical Center | Academic/Hospital | 1 | 0 | 1 | 2008 |
| People's Liberation Army of China | Government | 1 | 1 | 1 | 2020 |
| Phage Pharmaceuticals, Inc. | For profit | 1 | 1 | 1 | 2012 |
| Shanghai Dermatology Hospital | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Warren General Hospital | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Zhittya Genesis Medicine, Inc. | Academic/Hospital | 1 | 1 | 1 | 2022 |
9 organizations
Page 1 / 1